GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Edn1 | decreases expression | EXP | | 6480464 | CTD | Cisplatin results in decreased expression of EDN1 mRNA | PMID:22023808 | Edn1 | increases secretion | EXP | | 6480464 | CTD | Cisplatin results in increased secretion of EDN1 protein | PMID:28902463 | Edn1 | multiple interactions | EXP | | 6480464 | CTD | montelukast inhibits the reaction [Cisplatin results in increased secretion of EDN1 protein] | PMID:28902463 | Edn1 | decreases response to substance | ISO | EDN1 (Homo sapiens) | 6480464 | CTD | EDN1 results in decreased susceptibility to Cisplatin | PMID:21656314 | Edn1 | increases expression | ISO | EDN1 (Homo sapiens) | 6480464 | CTD | Cisplatin results in increased expression of EDN1 mRNA | PMID:21674241 | Edn1 | multiple interactions | ISO | EDN1 (Homo sapiens) | 6480464 | CTD | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 results in decreased susceptibility to Cisplatin] | PMID:21656314 | |
Go Back to source page | Continue to Ontology report |